Nomura Asset Management
RVMD icon

Nomura Asset Management’s Revolution Medicines RVMD Stock Holding History

Nomura Asset Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.74M Buy
51,993
+6,073
+13% +$887K 0.02% 476
2026
Q1 		$4.47M Buy
+45,920
New +$4.64M 0.01% 613
2024
Q4 		– Sell
-2,064
Closed -$104K – 1506
2024
Q3 		$93.6K Sell
2,064
-591
-22% -$25.7K ﹤0.01% 960
2024
Q2 		$103K Buy
2,655
+414
+18% +$15.5K ﹤0.01% 941
2024
Q1 		$72.2K Buy
2,241
+301
+16% +$8.92K ﹤0.01% 992
2023
Q4 		$55.6K Buy
1,940
+157
+9% +$3.77K ﹤0.01% 1031
2023
Q3 		$49.4K Sell
1,783
-1,529
-46% -$45.3K ﹤0.01% 1036
2023
Q2 		$88.6K Buy
+3,312
New +$81.3K ﹤0.01% 981

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Nomura Asset Management's RVMD Position: Q2 2026 in Review

Nomura Asset Management increased its Revolution Medicines (RVMD) stake by 13% in Q2 2026, buying an estimated $887K and bringing the position to 51,993 shares worth $9.74M. The position accounts for 0.02% of the portfolio, ranked #476.

Nomura Asset Management first reported a position in RVMD in Q2 2023 and has held it in 8 quarters since. 688 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Nomura Asset Management held 51,993 shares of Revolution Medicines worth $9.74M as of Q2 2026.
  • Nomura Asset Management bought 6,073 Revolution Medicines shares in Q2 2026, an estimated $887K.
  • Revolution Medicines made up 0.02% of Nomura Asset Management's portfolio in Q2 2026, its #476 holding.
  • Nomura Asset Management first reported a position in Revolution Medicines in Q2 2023 and has held it in 8 quarters since.
  • 688 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Nomura Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.